In pancreatic cancer cells, mir-29c directly targets and down-regulates USP22, increasing chemotherapy sensitivity and inducing apoptosis by inhibiting USP22-mediated autophagy [128]. This evidence concerns the gene USP22 and familial pancreatic carcinoma.